Provider review
Eviora MD review
By The Dose Brief Desk · Updated
Eviora offers bundled compounded GLP-1 care, but its medication-specific quote and conflicting cancellation deadlines deserve attention before enrollment.
Not rated. This review examines published program information; it is not a firsthand treatment review.
At a glance
- Semaglutide
- Available by consultation; no medication-specific price established.
- Tirzepatide
- Available by consultation; no medication-specific price established.
- Availability
- The contact page limits service to licensed states; confirm eligibility rather than relying on the nationwide headline.
- Treatment formats
- Compounded semaglutide and tirzepatide injections; a separate microdose program is advertised.
Terms describe recurring charges every 30 days. The treatment FAQ asks for 30 days of cancellation notice; the terms describe a 48-hour cutoff.
What the advertised price tells you
Eviora’s homepage advertises programs from $149 a month, but the semaglutide and tirzepatide pages do not assign that amount to either drug. Treat it as a starting headline, not a quote for your prescription. The treatment pages describe a bundled program with medication, provider-directed adjustments, secure messaging and delivery, without separate consultation or dose-change charges.
Two different cancellation deadlines
The product FAQ requests 30 days of notice before the next billing cycle. The legal subscription clause instead allows the auto-refill setting to be turned off up to 48 hours before monthly processing and describes charges every 30 days. These are materially different deadlines. Get the rule for your selected plan in writing and keep the confirmation rather than assuming that cancel-anytime wording prevents the next charge.
Who is behind the site?
The contact page identifies EVIORA LLC at 2807 N Parham Road, Suite 320 #7683, Henrico, Virginia, with weekday support. Its disclaimer distinguishes the platform from independent prescribers and pharmacies. The reviewed pages did not name the pharmacy that would fill an individual prescription. Ask for that identity before payment; the address alone does not establish a clinical facility.
Our assessment
Eviora’s practical appeal is the bundled follow-up model. Its unresolved drug-specific price and inconsistent notice periods make it harder to compare with a fully quoted monthly plan. We reviewed public information, not the enrollment or treatment experience. Compounded medication is not FDA-approved.
What stands out
- Describes medication, messaging, adjustments and delivery together
- Publishes an operator name and contact details
What to check
- No verified drug-specific price
- FAQ and legal cancellation deadlines conflict
Sources and review scope
Public information checked in October 2026. Prices and eligibility can change. We have not enrolled in treatment, independently tested medications or verified the licenses of the clinicians and pharmacies involved in an individual prescription. Compounded medications are not FDA-approved; studies of approved brands do not establish that a compounded product has the same safety or effectiveness.